Veriton Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
- Paid Up Capital ₹ 0.60 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
About Veriton Pharma
Veriton Pharma Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 August 2020 (Four years and five months 21 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Snehalkumar Soni, Maheshkumar Patel, Darshan Patel, and Three other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24239GJ2020PTC115392
- Company No.
115392
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Veriton Pharma?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Snehalkumar Soni  | Director | 08-Aug-2020 | Current |
| Maheshkumar Patel | Director | 08-Aug-2020 | Current |
| Darshan Patel | Director | 08-Aug-2020 | Current |
| Vasudev Patel | Director | 12-Oct-2020 | Current |
| Bhaveshkumar Patel | Director | 12-Oct-2020 | Current |
| Bipinchandra Patel | Director | 12-Oct-2020 | Current |
Financial Performance of Veriton Pharma.
Enhance accessibility to Veriton Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Veriton Pharma?
Unlock access to Veriton Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Claroid Pharmaceuticals LimitedSnehalkumar Soni is a mutual person
Brohks Healthcare Private LimitedSnehalkumar Soni is a mutual person
- Fly First Consultancy Private Limited
Darshan Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Veriton Pharma?
Veriton Pharma has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Veriton Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Veriton Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.